ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Choosing the right funds for a retirement portfolio requires balance of cost and coverage. Review 2024 options and practical selection tips.
26,319 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Bill Ackman’s Microsoft stake is shifting the AI investing playbook, spotlighting OpenAI ties and geopolitical risk a...
A boutique investment firm has just revealed a fresh stake in a gold producer. The move, described as Yakira Capital ...
SoftBank Group stock tumbled about 20% over the past five trading days as questions surrounding OpenAI funding and th...
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Microsoft plans to cut more than 3,000 jobs in its Xbox division as part of a broader cost-reduction effort. The move...
MicroStrategy’s once-buzzing retail following on Reddit is fading fast as the company sells crypto to fund dividends ...
Marvell Technology is due to report Q4 results after the bell, with investors watching whether the company can beat e...
A colossal DeFi trade on AAVE's swap interface left a trader facing a near $50 million loss after a mispriced swap. R...
A major national poll released this week reveals broad dissatisfaction with the economy, a finding that may influence...
Kroger's margin-led growth and private-label strength are driving a re-rating away from Walmart's ad-driven model, si...
Investors buzzed as metals company stock rocketed higher on regulatory progress and strong demand signals for battery...